Subcutaneous Fat Necrosis During Nivolumab Therapy for Metastatic Melanoma
Report describes 78-year-old woman with metastatic melanoma who was treated with nivolumab for 10 months who presented with multiple subcutaneous nodules. Nivolumab was subsequently withheld, and a trial of prednisone was administered followed by mild improvement.
Source:
JAMA Dermatology